PVLA Palvella Therapeutics, Inc. - Common Stock
$152,77
Prezzo · Ago 18, 2026
Fondamentali al Ago 4, 2026
Intervallo 52 sett.
$46–$161
93% of range
Rating Analisti
BUY
22 analysts
Prezzo Obiettivo
$231
+51% upside
P/E (TTM)
-41.2
ROE
-110.1%
Margine di Profitto Netto
-1610.6%
PVLA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$152.77
Capitalizzazione di Mercato
$1.89B
P/E (TTM)
-41.2
EPS (TTM)
$-3.71
Ricavi (TTM)
$43M
Rendimento div.
—
ROE
-110.1%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$46 – $161
PVLA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$43M
2017-12-31
→
2023-12-31
EPS
$-3.71
2020-12-31
→
2025-12-31
Flusso di cassa libero
—
2017-12-31
→
2022-12-31
Margini
-1610.6%
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
PVLA
Mediana dei peer
P/E (TTM)
-41.2
55.4
P/S (TTM)
96.6
7.7
P/B
67.6
7.1
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
PVLA
Mediana dei peer
Operating Margin (Margine Operativo)
-1490.4%
—
Net Profit Margin (Margine di Profitto Netto)
-1610.6%
-2.0%
ROA
-56.5%
-32.7%
ROE
-110.1%
-37.9%
ROIC
-137.9%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
PVLA
Mediana dei peer
Current Ratio (Rapporto corrente)
5.2
7.4
Quick Ratio
5.1
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
PVLA
Mediana dei peer
Revenue YoY (Ricavi YoY)
65.3%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
13.4%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
PVLA
Mediana dei peer
PVLA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
22 analisti
- Acquisto forte 6 27,3%
- Compra 15 68,2%
- Mantieni 1 4,5%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
15 analisti · 2026-08-17
Mediana
$232.00
← Sotto tutti i target
$152.77
Basso
$205.00
Alto
$270.00
Target mediano
$232.00
+51,9%
Target medio
$230.53
+50,9%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-0.37%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $-1.52 | $-1.18 | -0.34% |
| 31 Marzo 2026 | $-1.20 | $-0.95 | -0.25% |
| 31 Dicembre 2025 | $-1.07 | $-0.93 | -0.14% |
| 30 Settembre 2025 | $-1.03 | $-0.86 | -0.17% |
| 30 Giugno 2025 | $-0.86 | $-0.76 | -0.10% |
| 31 Marzo 2025 | $-0.74 | $-1.24 | 0.50% |
| 31 Dicembre 2024 | $-2.72 | $-0.66 | -2.1% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | — |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | — |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | — |
| VERA | — | -10.9 | — | — | -55.9% | — |
| MLYS | $2.96B | -15.8 | — | — | -32.2% | — |
| VCEL | $1.82B | 112.5 | 16.4% | 6.0% | 5.0% | 74.4% |
| BHVN | $1.50B | -1.6 | — | — | -310.8% | — |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | — |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 15
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $43M | $26M | $31M | $29M | $46M | $29M | $25M | $6M | $3M | $5M | |
| R&D Expense | $23M | $8M | $9M | $53M | $67M | $47M | $55M | $41M | $22M | $20M | $8M | $6M | |
| SG&A Expense | $16M | $6M | $3M | $16M | $17M | $17M | $18M | $18M | $18M | $9M | $8M | $7M | |
| Operating Expenses | $39M | $14M | $12M | $69M | $83M | $63M | $73M | $60M | $40M | $29M | $17M | $13M | |
| Operating Income | $-39M | $-14M | $-12M | $-43M | $-52M | $-34M | $-27M | $-31M | $-15M | $-23M | $-14M | $-7M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Other Non-op | $727.0K | $-131.0K | $712.0K | $1M | $2M | $-4M | $-26.0K | $2M | $-2M | $120.0K | $10.9K | $3.0K | |
| Pretax Income | $-42M | $-17M | $19M | $-33M | $-46M | $-37M | $-25M | $-27M | $-17M | $-23M | $-14M | $-10M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $164.0K | $0 | $-312.0K | $1M | $162.0K | $203.9K | $-18 | |
| Net Income | $-42M | $-17M | $19M | $-33M | $-46M | $-37M | $-25M | $-27M | $-18M | $-23M | $-14M | $-10M | |
| EPS (Basic) | $-3.71 | $-7.83 | $2.19 | $-0.45 | $-0.71 | $-0.68 | · | · | · | · | · | · | |
| EPS (Diluted) | $-3.71 | $-7.83 | $2.17 | · | $-0.71 | $-0.68 | · | · | · | · | · | · | |
| Shares (Basic) | 11,251,250 | 2,225,934 | 1,770,167 | 74,172,000 | 64,547,000 | 54,481,000 | · | · | · | · | · | · | |
| Shares (Diluted) | 11,251,250 | 2,225,934 | 1,793,980 | · | 64,547,000 | 54,481,000 | · | · | · | · | · | · | |
| EBITDA | $-39M | $-14M | · | $-41M | · | $-34M | $-27M | $-31M | $-15M | · | · | · |
Stato Patrimoniale 24
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $58M | $84M | $7M | $39M | $118M | $70M | $62M | $75M | $38M | $29M | $29M | $18M | |
| Short-term Investments | $0 | · | $9M | $21M | $0 | $0 | $42M | $53M | $35M | $0 | · | · | |
| Receivables | $0 | $358.0K | $0 | $6M | $3M | $2M | $7M | $3M | $16M | $57.0K | $0 | $0 | |
| Prepaid Expense | $1M | $2M | $198.0K | $3M | $7M | $4M | $4M | $5M | $2M | $3M | $2M | $1M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Assets | $59M | $88M | $8M | $73M | $128M | $76M | $115M | $135M | $90M | $33M | $32M | $20M | |
| PP&E (Net) | · | · | $0 | $17M | $19M | $22M | $20M | $5M | $4M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | · | $27M | $27M | $28M | $23M | $8M | $7M | $5M | $4M | $4M | |
| Accum. Depreciation | · | · | · | $10M | $8M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | |
| Other Non-current Assets | · | · | $0 | $1M | $3M | $3M | $3M | $910.0K | $130.0K | $126.0K | $126.8K | · | |
| Total Assets | $60M | $88M | $8M | $95M | $154M | $105M | $141M | $141M | $104M | $35M | $34M | $22M | |
| Accounts Payable | $5M | $5M | $936.0K | $4M | $9M | $2M | $6M | $3M | $2M | $2M | $1M | · | |
| Accrued Liabilities | · | · | · | · | · | $8M | $10M | $9M | $6M | $4M | $2M | $986.6K | |
| Current Liabilities | $11M | $12M | $2M | $37M | $51M | $22M | $27M | $48M | $46M | $8M | $3M | $4M | |
| Capital Leases | $431.0K | $0 | $0 | $12M | $14M | $16M | $15M | $0 | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | $0 | $0 | $6.0K | $0 | $27.0K | $37.0K | $47.0K | $23.9K | $334.0K | |
| Total Liabilities | $32M | $26M | $11M | $68M | $103M | $74M | $90M | $101M | $92M | $10M | $3M | $4M | |
| Common Stock | $12.0K | $11.0K | $0 | $74.0K | $72.0K | $56.0K | $55.0K | $54.0K | $45.0K | $43.0K | $39.8K | $29.3K | |
| Paid-in Capital | $163M | $156M | $2M | $319M | $307M | · | · | · | · | · | $112M | $85M | |
| Retained Earnings | $-135M | $-94M | $-76M | $-290M | $-257M | $-211M | $-174M | $-147M | $-120M | $-103M | $-80M | $-66M | |
| AOCI | $83.0K | $3.0K | $0 | $-254.0K | $829.0K | $-295.0K | $-2M | $-3M | $-5M | $-2M | $-1M | $-843.1K | |
| Stockholders' Equity | $28M | $63M | $-74M | $-94M | $51M | $31M | $51M | $40M | $12M | $25M | $31M | $18M | |
| Liabilities + Equity | $60M | $88M | $8M | $95M | $154M | $105M | $141M | $141M | $104M | $35M | $34M | $22M | |
| Shares Outstanding | 12,380,933 | 11,012,105 | 1,770,167 | 74,519,103 | 72,222,661 | 56,003,000 | 55,212,437 | 54,151,219 | 45,017,062 | 43,058,827 | 39,833,023 | 29,279,522 |
Flusso di cassa 13
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $2M | $3M | $2M | · | · | · | · | · | · | · | |
| Stock-based Comp | $6M | $830.0K | $603.0K | $4M | $5M | $5M | $5M | $5M | $3M | $2M | $1M | $571.4K | |
| Deferred Tax | · | · | $0 | $0 | $0 | $0 | $0 | $-164.0K | $0 | $0 | $0 | $0 | |
| Other Non-cash | · | · | · | $-34M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-25M | $-11M | $-14M | $-60M | $-8M | $-46M | $-52M | $-1M | $50M | $-14M | $-13M | $-5M | |
| CapEx | · | · | $171.0K | $1M | $949.0K | $3M | $2M | $2M | $2M | $560.0K | $620.7K | $267.4K | |
| Investing Cash Flow | · | · | $12M | $-21M | $-949.0K | $39M | $10M | $-9M | $-46M | · | · | · | |
| Stock Issued | · | · | $20M | $7M | $38M | $10M | · | · | · | · | $26M | $12M | |
| Net Stock Activity | · | · | · | $7M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-660.0K | $87M | $5M | $7M | $59M | $10M | $32M | $49M | $4M | · | · | · | |
| Net Change in Cash | $-26M | $76M | $-9M | $-79M | $47M | $8M | $-13M | $37M | $9M | $6.0K | $11M | $15M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | $51.7K | |
| Free Cash Flow | · | · | · | $-61M | · | $-49M | $-55M | $-3M | $48M | · | · | · |
Redditività 7
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1490.4% | · | · | -167.8% | · | -115.7% | -58.7% | -105.9% | -57.7% | · | · | · | |
| Net Margin | -1610.6% | · | · | -128.5% | · | -127.0% | -55.0% | -91.9% | -69.8% | · | · | · | |
| Pretax Margin | -1610.6% | · | · | -128.5% | · | -126.4% | -55.0% | -93.0% | -65.5% | · | · | · | |
| EBITDA Margin | -1490.4% | · | · | -157.1% | · | -115.7% | -58.7% | -105.9% | -57.7% | · | · | · | |
| ROA | -56.5% | -36.4% | · | -26.7% | · | -30.3% | -17.9% | -21.8% | -25.4% | · | · | · | |
| ROE | -110.1% | 140.6% | · | -92.1% | · | -99.7% | -70.8% | -59.3% | -96.0% | · | · | · | |
| ROIC | -137.9% | -22.5% | · | -155.7% | · | -109.8% | -52.9% | -76.3% | -135.1% | · | · | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.2 | 7.3 | · | 2.0 | · | 3.4 | 4.3 | 2.8 | 2.0 | · | · | · | |
| Quick Ratio | 5.1 | 7.0 | · | 1.8 | · | 3.3 | 4.1 | 2.7 | 1.9 | · | · | · |
Efficienza 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.2 | · | 0.2 | 0.3 | 0.2 | 0.4 | · | · | · | |
| Receivables Turnover | 14.5 | · | · | 5.7 | · | 6.9 | 9.8 | 3.2 | 3.2 | · | · | · |
Tassi di Crescita 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | 65.3% | -17.6% | 7.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | · | 13.4% | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20M | $20M | $43M | $26M | $31M | $29M | $46M | $29M | $25M | $6M | $3M | $5M | |
| Net Income TTM | $-42M | $-17M | $19M | $-33M | $-46M | $-37M | $-25M | $-27M | $-18M | $-23M | $-14M | $-10M | |
| Market Cap | $1.30B | $132M | · | $6.20B | · | $11.20B | $15.99B | $11.52B | $27.19B | · | · | · | |
| P/E | -28.2 | -1.5 | 6.7 | -118.9 | -425.9 | -294.1 | · | · | · | · | · | · | |
| P/S | 66.2 | 6.8 | · | 239.4 | · | 382.0 | 345.5 | 396.0 | 1075.8 | · | · | · | |
| P/B | 46.3 | 2.1 | · | 222.0 | · | 361.0 | 311.4 | 288.6 | 2359.9 | · | · | · | |
| P / Tangible Book | 46.3 | 2.1 | · | · | 430.3 | 361.0 | · | · | · | · | · | · | |
| P / Cash Flow | -51.8 | -12.2 | · | -103.5 | · | -244.0 | -304.8 | -10809.9 | 546.5 | · | · | · | |
| P / FCF | · | · | · | -101.7 | · | -230.4 | -291.1 | -4169.1 | 568.8 | · | · | · | |
| Earnings Yield | -3.5% | -65.2% | 14.9% | -0.84% | -0.23% | -0.34% | · | · | · | · | · | · |
Conto Economico 14
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | $0 | $0 | $53.0K | · | $20M | $20M | $2M | $6M | $5M | |
| R&D Expense | $12M | $9M | $7M | $7M | $5M | $4M | $3M | $3M | $1M | $984.0K | $-29M | $10M | $14M | $13M | $13M | $14M | |
| SG&A Expense | $9M | $6M | $4M | $4M | $4M | $4M | $2M | $2M | $1M | $775.0K | $-11M | $7M | $4M | $4M | $4M | $4M | |
| Operating Expenses | $21M | $15M | $11M | $10M | $9M | $8M | $4M | $5M | $3M | $2M | $-55M | $31M | $18M | $17M | $17M | $18M | |
| Operating Income | $-21M | $-15M | $-11M | $-10M | $-9M | $-8M | $-4M | $-5M | $-3M | $-2M | $13M | $-12M | $2M | $-16M | $-12M | $-12M | |
| Other Non-op | $-8.0K | $-32.0K | $-92.0K | $34.0K | $561.0K | $224.0K | $-175.0K | $-20.0K | $64.0K | $0 | $424.0K | $506.0K | $-161.0K | $-57.0K | $-325.0K | $723.0K | |
| Pretax Income | $-22M | $-16M | $-13M | $-11M | $-9M | $-8M | $-4M | $-7M | $-4M | $-3M | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-22M | $-16M | $-13M | $-11M | $-9M | $-8M | $-4M | $-7M | $-4M | $-3M | $39M | $-11M | $4M | $-13M | $-8M | $-10M | |
| EPS (Basic) | $-1.52 | $-1.20 | $-1.08 | $-1.03 | $-0.86 | $-0.74 | $0.12 | $-3.94 | $-2.47 | $-1.54 | $21.41 | $-8.70 | $3.63 | $-14.15 | $-0.11 | $-0.13 | |
| EPS (Diluted) | $-1.52 | $-1.20 | $-1.08 | $-1.03 | $-0.86 | $-0.74 | $0.12 | $-3.94 | $-2.47 | $-1.54 | $20.50 | $-8.70 | $3.62 | · | · | · | |
| Shares (Basic) | 14,356,219 | 13,085,271 | -21,879,470 | 11,064,282 | 11,052,741 | 11,013,697 | -3,084,567 | 1,770,167 | 1,770,167 | 1,770,167 | -1,491,833 | 1,236,000 | 1,095,000 | 931,000 | -148,061,000 | 74,397,000 | |
| Shares (Diluted) | 14,356,219 | 13,085,271 | -21,879,470 | 11,064,282 | 11,052,741 | 11,013,697 | -3,084,567 | 1,770,167 | 1,770,167 | 1,770,167 | 704,980 | 1,236,000 | 1,098,000 | · | · | · | |
| EBITDA | $-21M | $-15M | · | $-10M | $-9M | $-8M | · | $-3M | $-4M | $-5M | · | $-12M | $2M | $-15M | · | $-12M |
Stato Patrimoniale 22
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $188M | $206M | $58M | $64M | $70M | $76M | $84M | $19M | $20M | $19M | $7M | $33M | $45M | $40M | $39M | $48M | |
| Short-term Investments | $63M | $55M | · | · | · | · | · | $0 | $0 | $0 | · | $12M | $10M | $9M | $21M | $21M | |
| Receivables | · | · | $0 | $0 | $0 | $0 | $358.0K | $373.0K | $1M | $2M | $0 | $1M | $952.0K | $1M | $6M | $829.0K | |
| Prepaid Expense | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $280.0K | $649.0K | $3M | $198.0K | $9M | $11M | $11M | $3M | $8M | |
| Current Assets | $253M | $263M | $59M | $67M | $74M | $79M | $88M | · | · | · | $8M | $59M | $66M | $61M | $73M | $79M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | $0 | $16M | $17M | $17M | $16M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | $27M | $27M | $27M | $24M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | $11M | $10M | $10M | $8M | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $287.0K | $1M | $1M | $1M | $1M | |
| Total Assets | $254M | $264M | $60M | $67M | $74M | $79M | $88M | $21M | $25M | $29M | $8M | $59M | $88M | $82M | $95M | $99M | |
| Accounts Payable | $7M | $5M | $5M | $3M | $5M | $4M | $5M | $801.0K | $969.0K | $2M | $936.0K | $3M | $8M | $6M | $4M | $4M | |
| Current Liabilities | $12M | $9M | $11M | $10M | $10M | $9M | $12M | $4M | $6M | $8M | $2M | $29M | $34M | $43M | $37M | $34M | |
| Capital Leases | $318.0K | $375.0K | $431.0K | · | · | · | $0 | · | · | · | · | $0 | $12M | $12M | $12M | $11M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Total Liabilities | $37M | $31M | $32M | $28M | $26M | $24M | $26M | · | · | · | $11M | $29M | $47M | $67M | $68M | $63M | |
| Common Stock | $14.0K | $14.0K | $12.0K | $11.0K | $11.0K | $11.0K | $11.0K | $1.0K | $1.0K | $1.0K | $0 | $99.0K | $99.0K | $74.0K | $74.0K | $74.0K | |
| Paid-in Capital | $390M | $383M | $163M | $161M | $159M | $157M | $156M | $343M | $343M | $342M | $2M | $341M | $340M | $319M | $319M | $317M | |
| Retained Earnings | $-173M | $-151M | $-135M | $-123M | $-111M | $-102M | $-94M | $-326M | $-323M | $-320M | $-76M | $-310M | $-300M | $-304M | $-290M | $-282M | |
| AOCI | $89.0K | $95.0K | $83.0K | $104.0K | $-111.0K | $-3.0K | $3.0K | $-316.0K | $-436.0K | $-346.0K | $0 | $-339.0K | $-137.0K | $-426.0K | $-254.0K | $524.0K | |
| Stockholders' Equity | $217M | $232M | $28M | $39M | $48M | $56M | $63M | $16M | $19M | $22M | $-74M | $31M | $40M | $15M | $28M | $36M | |
| Liabilities + Equity | $254M | $264M | $60M | $67M | $74M | $79M | $88M | $21M | $25M | $29M | $8M | $59M | $88M | $82M | $95M | $99M | |
| Shares Outstanding | 14,395,705 | 14,313,659 | 12,380,933 | 11,088,329 | 11,059,665 | 11,021,389 | 11,012,105 | 1,320,240 | 1,320,240 | 1,236,688 | 1,770,167 | · | 98,851,927 | 74,519,103 | 74,519,103 | 74,406,253 |
Flusso di cassa 11
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $0 | $0 | $-30.0K | · | $739.0K | $758.0K | $605.0K | $575.0K | $767.0K | |
| Stock-based Comp | $5M | $3M | $2M | $2M | $1M | $1M | $268.0K | $-331.0K | $-109.0K | $146.0K | $-2M | $966.0K | $1M | $884.0K | $949.0K | $974.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $-7M | · | · | · | $1M | · | · | |
| Operating Cash Flow | $-13M | $-11M | $-5M | $-8M | $-5M | $-7M | $-5M | $3M | $4M | $-1M | $20M | $-10M | $-13M | $-11M | $-13M | $-9M | |
| CapEx | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $69.0K | $67.0K | $48.0K | $-11.0K | $34.0K | |
| Investing Cash Flow | $-7M | $-55M | · | · | $0 | $0 | · | $142.0K | $2M | $9M | · | $-2M | $-1M | $12M | $1M | $5M | |
| Stock Issued | $0 | $230M | · | · | $0 | $0 | · | $0 | · | · | · | $0 | $20M | $0 | $0 | $282.0K | |
| Net Stock Activity | · | $230M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $1M | $215M | $-49.0K | $242.0K | $349.0K | $-1M | $75M | $12M | $10M | $0 | $-15M | $0 | $20M | $0 | $93.0K | $282.0K | |
| Net Change in Cash | $-19M | $148M | $-6M | $-7M | $-5M | $-8M | $69M | $5M | $5M | $-1M | $-3M | $-12M | $5M | $1M | $-10M | $-6M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-7M | · | · | · | $-11M | · | · |
Redditività 7
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1089.3% | -1384.4% | · | -1620.5% | -1340.6% | -1046.7% | · | · | · | -10005.7% | · | -60.5% | 10.3% | -801.2% | · | -226.6% | |
| Net Margin | -1113.0% | -1469.4% | · | -1806.5% | -1372.6% | -1088.4% | · | · | · | -9230.2% | · | -55.1% | 19.8% | -680.9% | · | -181.3% | |
| Pretax Margin | -1113.0% | -1469.4% | · | -1806.5% | -1372.6% | -1088.4% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1089.3% | -1384.4% | · | -1620.5% | -1340.6% | -1046.7% | · | · | · | -10062.3% | · | -60.5% | 10.3% | -769.9% | · | -226.6% | |
| ROA | -13.4% | -9.2% | · | -25.9% | -19.2% | -15.0% | · | -7.2% | -6.4% | -8.8% | · | -13.6% | 3.9% | -12.0% | · | -7.4% | |
| ROE | -16.5% | -10.9% | · | -41.3% | -28.5% | -21.1% | · | -12.3% | -12.1% | -26.2% | · | -32.5% | 9.4% | -38.3% | · | -21.7% | |
| ROIC | -9.9% | -6.4% | · | -26.3% | -19.4% | -14.2% | · | · | · | · | · | · | · | · | · | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 21.2 | 28.9 | · | 6.5 | 7.7 | 8.8 | · | · | · | · | · | 2.0 | 1.9 | 1.4 | · | 2.3 | |
| Quick Ratio | 21.0 | 28.7 | · | 6.2 | 7.3 | 8.4 | · | 4.6 | 3.3 | 2.8 | · | 1.6 | 1.6 | 1.2 | · | 2.1 |
Efficienza 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.2 | 0.2 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | 3.4 | 0.9 | 0.8 | · | 0.0 | 0.0 | 0.0 | · | 20.8 | 18.1 | 1.4 | · | 1.4 |
Valutazione (TTM) 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20M | $20M | · | $20M | $20M | $20M | · | $20M | $40M | $42M | · | $47M | $31M | $22M | · | $24M | |
| Net Income TTM | $-58M | $-45M | · | $-36M | $-29M | $-22M | · | $-24M | $-13M | $-22M | · | $-30M | $-29M | $-38M | · | $-42M | |
| Market Cap | $2.20B | $1.78B | · | $695M | $249M | $308M | · | $22M | $13M | $18M | · | · | $1.31B | $5.82B | · | $6.85B | |
| P/E | -33.1 | -32.5 | · | -9.5 | -2.8 | -3.2 | · | -1.0 | -1.1 | · | · | · | · | -111.5 | · | -131.4 | |
| P/S | 112.4 | 91.2 | · | 35.5 | 12.7 | 15.8 | · | 1.1 | 0.3 | 0.4 | · | · | 42.3 | 264.6 | · | 283.9 | |
| P/B | 10.1 | 7.7 | · | 18.0 | 5.2 | 5.6 | · | 1.3 | 0.7 | 0.8 | · | · | 32.4 | 376.4 | · | 191.4 | |
| P / Tangible Book | 10.1 | 7.7 | · | 18.0 | 5.2 | 5.6 | · | 1.3 | 0.7 | 0.8 | · | · | 32.4 | 376.4 | · | 191.4 | |
| P / Cash Flow | · | -164.2 | · | · | · | -45.6 | · | · | · | -2.6 | · | · | · | -529.1 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -2.6 | · | · | · | -526.8 | · | · | |
| Earnings Yield | -3.0% | -3.1% | · | -10.5% | -35.5% | -31.1% | · | -100.4% | -92.7% | · | · | · | · | -0.90% | · | -0.76% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | — | — | $43M | $26M | $31M |
| Margine Operativo % | -1490.4% | — | — | -167.8% | — |
| Utile netto | $-42M | $-17M | $19M | $-33M | $-46M |
| EPS Diluito | $-3.71 | $-7.83 | $2.17 | — | $-0.71 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rapporto corrente | 5.2 | 7.3 | — | 2.0 | — |
| Quick Ratio | 5.1 | 7.0 | — | 1.8 | — |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | — | — | — | $-61M | — |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 211 filer · $1.9B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 43 (-20 vs trimestre precedente) | 19 (-3 vs trimestre precedente) | 86 (+21 vs trimestre precedente) | 46 (+13 vs trimestre precedente) | +1.4M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $173.512.745 | 1.135.406 | 9,19% | Azioni |
| Frazier Life Sciences Management, L.P. | $134.848.368 | 882.400 | 7,15% | Azioni |
| JENNISON ASSOCIATES LLC | $124.781.044 | 816.523 | 6,61% | Azioni |
| First Light Asset Management, LLC | $117.961.911 | 771.901 | 6,25% | Azioni |
| BVF INC/IL | $102.815.615 | 672.789 | 5,45% | Azioni |
| STATE STREET CORP | $99.817.745 | 653.172 | 5,29% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $78.517.999 | 513.794 | 4,16% | Azioni |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $73.175.272 | 478.833 | 3,88% | Azioni |
| FEDERATED HERMES, INC. | $66.173.352 | 433.015 | 3,51% | Azioni |
| VANGUARD GROUP INC | $51.885.966 | 495.710 | 2,75% | Azioni |
| Woodline Partners LP | $48.522.948 | 317.517 | 2,57% | Azioni |
| ORBIMED ADVISORS LLC | $44.678.455 | 292.360 | 2,37% | Azioni |
| Siren, L.L.C. | $39.348.858 | 257.485 | 2,09% | Azioni |
| PRIMECAP MANAGEMENT CO/CA/ | $39.149.734 | 256.182 | 2,07% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $36.385.548 | 238.031 | 1,93% | Azioni |
| EVENTIDE ASSET MANAGEMENT, LLC | $35.375.385 | 231.484 | 1,87% | Azioni |
| EMERALD ADVISERS, LLC | $35.070.051 | 229.486 | 1,86% | Azioni |
| FMR LLC | $32.814.733 | 214.728 | 1,74% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $31.557.391 | 253.168 | 1,67% | Azioni |
| MPM BIOIMPACT LLC | $31.179.406 | 204.027 | 1,65% | Azioni |
| GOLDMAN SACHS GROUP INC | $28.993.469 | 189.723 | 1,54% | Azioni |
| First Turn Management, LLC | $23.908.689 | 156.450 | 1,27% | Azioni |
| Bellevue Group AG | $23.687.100 | 155.000 | 1,26% | Azioni |
| Caption Management, LLC | $21.394.800 | 140.000 | 1,13% | Opzione Put |
| EMERALD MUTUAL FUND ADVISERS TRUST | $19.843.219 | 129.847 | 1,05% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $19.707.973 | 128.962 | 1,04% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18.430.092 | 120.600 | 0,98% | Opzione Call |
| Aberdeen Group plc | $18.374.771 | 120.238 | 0,97% | Azioni |
| NEXTBio Capital Management LP | $13.739.893 | 89.909 | 0,73% | Azioni |
| Clio Asset Management LLC | $13.194.937 | 86.343 | 0,70% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.706.012 | 76.600 | 0,62% | Opzione Put |
| VANGUARD FIDUCIARY TRUST CO | $11.307.916 | 73.995 | 0,60% | Azioni |
| Avidity Partners Management LP | $10.697.400 | 70.000 | 0,57% | Azioni |
| AWM Investment Company, Inc. | $10.608.153 | 69.416 | 0,56% | Azioni |
| SEVEN GRAND MANAGERS, LLC | $9.169.200 | 60.000 | 0,49% | Azioni |
| Clearbridge Investments, LLC | $9.068.458 | 59.341 | 0,48% | Azioni |
| NEUBERGER BERMAN GROUP LLC | $8.445.444 | 55.264 | 0,45% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $8.140.721 | 53.270 | 0,43% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $7.979.038 | 52.212 | 0,42% | Azioni |
| Ensign Peak Advisors, Inc | $7.894.681 | 51.660 | 0,42% | Azioni |
| Nicholas Investment Partners, LP | $7.597.905 | 49.718 | 0,40% | Azioni |
| Balyasny Asset Management L.P. | $6.805.992 | 44.536 | 0,36% | Azioni |
| Lisanti Capital Growth, LLC | $6.567.440 | 42.975 | 0,35% | Azioni |
| WCM INVESTMENT MANAGEMENT, LLC | $6.215.278 | 40.140 | 0,33% | Azioni |
| ROYCE & ASSOCIATES LP | $6.190.585 | 40.509 | 0,33% | Azioni |
| ORBIMED ADVISORS LLC | $6.112.800 | 40.000 | 0,32% | Opzione Call |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $6.092.169 | 39.865 | 0,32% | Azioni |
| Apis Capital Advisors, LLC | $5.959.980 | 39.000 | 0,32% | Azioni |
| Blue Owl Capital Holdings LP | $5.541.100 | 36.259 | 0,29% | Azioni |
| FIFTH THIRD BANCORP | $5.438.100 | 35.585 | 0,29% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4.979.334 | 32.583 | 0,26% | Azioni |
| FRED ALGER MANAGEMENT, LLC | $4.802.216 | 31.424 | 0,25% | Azioni |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | $4.786.017 | 31.318 | 0,25% | Azioni |
| CITADEL ADVISORS LLC | $4.645.728 | 30.400 | 0,25% | Opzione Call |
| Caption Management, LLC | $4.584.600 | 30.000 | 0,24% | Opzione Call |
| BANK OF AMERICA CORP /DE/ | $4.577.265 | 29.952 | 0,24% | Azioni |
| JANE STREET GROUP, LLC | $4.095.576 | 26.800 | 0,22% | Opzione Call |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $3.820.500 | 25.000 | 0,20% | Azioni |
| NOMURA HOLDINGS INC | $3.662.026 | 23.963 | 0,19% | Azioni |
| Legato Capital Management LLC | $3.589.741 | 23.490 | 0,19% | Azioni |
| TD Asset Management Inc | $3.476.044 | 22.746 | 0,18% | Azioni |
| ACT CAPITAL MANAGEMENT, LLC | $3.438.450 | 22.500 | 0,18% | Azioni |
| Swiss National Bank | $2.964.708 | 19.400 | 0,16% | Azioni |
| Informed Momentum Co LLC | $2.880.504 | 18.849 | 0,15% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $2.762.833 | 18.079 | 0,15% | Azioni |
| F/m Investments LLC | $2.666.098 | 17.446 | 0,14% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.658.610 | 17.397 | 0,14% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2.375.587 | 15.545 | 0,13% | Azioni |
| CITIGROUP INC | $2.270.905 | 14.860 | 0,12% | Azioni |
| ALPS ADVISORS INC | $2.193.884 | 14.356 | 0,12% | Azioni |
| Capricorn Fund Managers Ltd | $2.152.928 | 14.088 | 0,11% | Azioni |
| RHUMBLINE ADVISERS | $2.067.339 | 13.528 | 0,11% | Azioni |
| Trexquant Investment LP | $2.062.306 | 13.495 | 0,11% | Azioni |
| CITADEL ADVISORS LLC | $2.032.506 | 13.300 | 0,11% | Opzione Put |
| BlackRock, Inc. | $1.945.093 | 12.728 | 0,10% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $1.878.769 | 12.294 | 0,10% | Azioni |
| OAK RIDGE INVESTMENTS LLC | $1.839.647 | 12.038 | 0,10% | Azioni |
| Cresset Asset Management, LLC | $1.777.144 | 11.629 | 0,09% | Azioni |
| VICTORY CAPITAL MANAGEMENT INC | $1.762.167 | 11.531 | 0,09% | Azioni |
| Rafferty Asset Management, LLC | $1.736.188 | 11.361 | 0,09% | Azioni |
| Bank of New York Mellon Corp | $1.633.340 | 10.688 | 0,09% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $1.593.913 | 10.430 | 0,08% | Azioni |
| Mariner, LLC | $1.583.364 | 10.361 | 0,08% | Azioni |
| Knights of Columbus Asset Advisors LLC | $1.532.937 | 10.031 | 0,08% | Azioni |
| XTX Topco Ltd | $1.354.138 | 8.861 | 0,07% | Azioni |
| MARTINGALE ASSET MANAGEMENT L P | $1.284.605 | 8.406 | 0,07% | Azioni |
| TUDOR INVESTMENT CORP ET AL | $1.208.195 | 7.906 | 0,06% | Azioni |
| MetLife Investment Management, LLC | $978.812 | 6.405 | 0,05% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $977.895 | 6.399 | 0,05% | Azioni |
| STATE OF WISCONSIN INVESTMENT BOARD | $976.825 | 6.392 | 0,05% | Azioni |
| Vanguard Global Advisers, LLC | $948.859 | 6.209 | 0,05% | Azioni |
| ASPIRIANT, LLC | $894.303 | 5.852 | 0,05% | Azioni |
| PROFUND ADVISORS LLC | $879.173 | 5.753 | 0,05% | Azioni |
| VOYA INVESTMENT MANAGEMENT LLC | $873.519 | 5.716 | 0,05% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $859.462 | 6.895 | 0,05% | Azioni |
| Penn Capital Management Company, LLC | $841.427 | 5.506 | 0,04% | Azioni |
| ExodusPoint Capital Management, LP | $839.593 | 5.494 | 0,04% | Azioni |
| Squarepoint Ops LLC | $790.996 | 5.176 | 0,04% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $787.176 | 5.151 | 0,04% | Azioni |
| CAPTRUST FINANCIAL ADVISORS | $722.991 | 4.731 | 0,04% | Azioni |
Insider aziendali 23 insider · 10 dirigenti · 15 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Kaupinen Wes | President and CEO | 05 Febbraio 2026 A | — | 0 | 0 | $0 |
| Stephen S. Yoder | Chief Executive Officer | 23 Febbraio 2017 A | 6.000 | 0 | 0 | $0 |
| Matthew E Korenberg | CFO, Treasurer | 12 Giugno 2026 M | 1.000 | 0 | 0 | $0 |
| Allan Reine | SVP and Chief Financial Officer | 17 Agosto 2017 P | 65.000 | 0 | 0 | $0 |
| Darlene M Deptula-Hicks | SVP, Chief Financial Officer | 13 Giugno 2016 P | 5.000 | 0 | 0 | $0 |
| Kathleen Goin | Chief Operating Officer | 15 Luglio 2026 M | 0 | 0 | 25 | $-4.196.766 |
| Ashley Hartmann Kline | Chief Commercial Officer | 05 Febbraio 2026 A | — | 0 | 0 | $0 |
| Jeffrey S Martini | Chief Scientific Officer | 05 Febbraio 2026 A | — | 0 | 0 | $0 |
| Louis Matis | SVP, Chief Development Officer | 23 Febbraio 2017 A | 10.000 | 0 | 0 | $0 |
| Claude Knopf | Chief Business Officer | 28 Novembre 2016 A | — | 0 | 0 | $0 |
| Matthew Pauls | Direttore | 29 Giugno 2026 A | — | 0 | 0 | $0 |
| Tadd S. Wessel | Direttore | 10 Giugno 2026 A | — | 0 | 0 | $0 |
| John Doux | Direttore | 10 Giugno 2026 A | — | 0 | 0 | $0 |
| Todd C Davis | Direttore | 10 Giugno 2026 A | — | 0 | 0 | $0 |
| George M Jenkins | Direttore | 10 Giugno 2026 A | 187.616 | 2 | 0 | $549.974 |
| Christopher P Kiritsy | Direttore | 10 Giugno 2026 A | 5.000 | 0 | 0 | $0 |
| Elaine J Heron | Direttore | 10 Giugno 2026 A | 47.812 | 1 | 0 | $300.000 |
| James A Geraghty | Direttore | 17 Agosto 2017 P | 10.000 | 0 | 0 | $0 |
| Chau Quang Khuong | Direttore | 25 Luglio 2017 A | 65.398 | 0 | 0 | $0 |
| Michael Richman | Direttore | 25 Luglio 2017 A | — | 0 | 0 | $0 |
| Jean-Pierre Bizzari | Direttore | 25 Gennaio 2017 A | — | 0 | 0 | $0 |
| Steven Prelack | Direttore | 25 Gennaio 2017 A | — | 0 | 0 | $0 |
| Julian Adams | Direttore | 25 Gennaio 2017 A | — | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 3 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Kaupinen Wes, Wesley H. Kaupinen 2019 Irrevocable Trust dated February 28, 2019, Christine L. Kaupinen, Christine L. Kaupinen 2019 Irrevocable Trust dated February 28, 2019, Michael Christopher | 20 Dicembre 2024 | 14,60% | Deposito iniziale | — | SEC |
| Biotechnology Value Fund, L.P., BVF I GP LLC, Biotechnology Value Fund II, L.P., BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP Holdings LLC, BVF Partners L.P., BVF Inc., Mark N. Lampert ×2 depositi | 17 Agosto 2023 | — | Deposito iniziale | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP III LLC ×10 depositi | 27 Settembre 2018 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 30 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 1,95% | 17.254 NS | 31 Maggio 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 1,03% | 14.096 NS | 31 Maggio 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,96% | 2.798 NS | 30 Aprile 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,39% | 15.705 NS | 30 Aprile 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,18% | 22.955 SH | 08 Agosto 2026 | Giornaliero |
| IWO · iShares Trust | 0,10% | 98.816 SH | 08 Agosto 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,10% | 11.762 SH | 08 Agosto 2026 | Giornaliero |
| SMMV · iShares Trust | 0,09% | 1.761 SH | 08 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | 0,05% | 277.644 SH | 08 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 63.184 SH | 08 Agosto 2026 | Giornaliero |
| GSSC · Goldman Sachs ETF Trust | 0,05% | 4.017 NS | 31 Maggio 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 3.330 NS | 30 Aprile 2026 | N-PORT |
| ISCG · iShares Trust | 0,02% | 1.578 SH | 08 Agosto 2026 | Giornaliero |
| ISCB · iShares Trust | 0,02% | 450 SH | 08 Agosto 2026 | Giornaliero |
| ITWO · ProShares Trust | 0,02% | 364 NS | 31 Maggio 2026 | N-PORT |
| ISCV · iShares Trust | 0,02% | 1.030 SH | 08 Agosto 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 4.496 NS | 30 Aprile 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 113.556 SH | 08 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,02% | 30.157 SH | 08 Agosto 2026 | Giornaliero |
| WSML · iShares Trust | 0,02% | 667 SH | 08 Agosto 2026 | Giornaliero |
| UWM · ProShares Trust | 0,01% | 285 NS | 31 Maggio 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 288 NS | 31 Maggio 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 3.843 NS | 31 Maggio 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 7 NS | 31 Maggio 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 232 NS | 31 Maggio 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 3.380 SH | 08 Agosto 2026 | Giornaliero |
| ITOT · iShares Trust | 0,00% | 14.741 SH | 08 Agosto 2026 | Giornaliero |
| DFAC · Dimensional ETF Trust | 0,00% | 218 NS | 30 Aprile 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 388.390 SH | 08 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 904 SH | 08 Agosto 2026 | Giornaliero |